Corporate Life Cycle Valuation: Why Growth Stocks Use PSR and Mature Stocks Use PER

Two Companies, Same Industry, Completely Different Yardsticks

PER, PBR, PSR and EV/EBITDA covered how to pick the right multiple for a company's current financial shape — PSR for an unprofitable company, EV/EBITDA for a heavily indebted one. But there's a piece missing: the same company's financial shape five years ago, today, and five years from now can look nothing alike. A money-losing startup doubling revenue every year can become a steady, dividend-paying company a decade later, and a former industry leader can end up selling off assets as revenue shrinks. This lesson follows a company through its entire arc — birth, growth, maturity, decline, what's known as the corporate life cycle — to explain why the valuation yardstick the market applies shifts at each stage, and why that shift matters to investors. It isn't a signal to buy or sell any specific stock based on which stage it's in.

The Five Stages of a Company's Life

NYU Stern professor Aswath Damodaran's corporate life cycle framework breaks a company's life into roughly five stages: ① an early startup stage still validating its product and market, ② a high-growth stage where revenue surges but reinvestment outpaces it, ③ a mature growth stage where growth slows but profits start flowing reliably, ④ a mature stable stage where growth has nearly stopped but cash flow is at its richest, and ⑤ a decline stage where revenue and profit shrink together. Not every company moves through these stages at the same pace — Damodaran himself notes that tech companies tend to pass through mature stability quickly, while manufacturers and utilities can linger there for decades as reliable "cash cows." Companies also don't always move through the stages in strict order: some reignite high growth from a new business line after reaching maturity, and some skip high growth altogether and slide straight into decline. The point of the framework isn't to force every company onto one fixed path — it's to give investors a reference point for asking which stage a company's current financial profile most resembles.

Three Things That Shift Together: Reinvestment, Cash Flow, Uncertainty

The reason this life cycle connects directly to valuation is that three things change together at each stage. The first is the reinvestment rate. In the early and high-growth stages, a company has to plow more money into plants, R&D and marketing than every dollar of revenue it brings in, just to hold its ground in the market. By the mature stable stage, the factories and brand built earlier generate far more cash than the business needs to reinvest. The second is the shape of cash flow: at a high reinvestment rate, reported revenue can be climbing while actual cash in hand stays close to zero or negative; only once reinvestment needs ease does free cash flow (FCF) turn reliably positive. The third is estimation uncertainty: a brand-new company has almost no track record to lean on, so its future rests heavily on a qualitative story — how big the market could get, why the team can out-execute rivals — while a company with a decade or more of consistent results can be projected within a fairly narrow range using historical data alone. Because all three shift together, holding a company to the same yardstick throughout its life is asking the wrong question at some point along the way.

So Different Metrics Take Over at Different Stages

As these three variables shift, the valuation approach that's commonly used in practice shifts along with them. The table below sketches which approach tends to dominate at each stage — a rough industry tendency, not a rule that applies mechanically to every company.

Life cycle stage	Typical financial profile	Commonly used approach
Early startup	Little to no revenue, no track record	Qualitative scorecards, pre-money/post-money valuation
High growth (often unprofitable)	Revenue surging, profit negative or thin	PSR, EV/Sales
Mature growth	Profitable, still double-digit growth	PEG, forward PER
Mature stable	Growth near flat, rich cash flow, dividends/buybacks	Trailing PER, EV/EBITDA, DCF, dividend yield
Decline	Revenue and profit both shrinking	PBR, liquidation value, FCF yield

Moving left to right across the table, the underlying question shifts — from "can this company become profitable at all" to "how much is it earning right now" to "what could its assets fetch if the business were wound down." Insisting on a PER for a loss-making startup, or on PEG — a growth-adjusted PER — for a company in decline, means asking a question the metric was never built to answer for a company in that situation.

Story vs. Numbers: What Actually Convinces an Investor Changes

Damodaran frames this shift as moving from "story to numbers." For an early-stage company, the case for its value is almost entirely narrative: how large the addressable market could become, why this team should out-execute competitors — questions that carry more weight than the financial statements themselves. At this stage, whether PSR sits at 10x or 20x matters less than whether the growth story behind it is credible. Once a company reaches mature stability, the balance flips. Years of accumulated revenue, profit and cash flow data exist, so numbers now carry far more weight than story. An investor in a mature company cares less about a ten-year market-size projection and more about whether operating margin has held steady for five straight years, or how many years in a row the dividend has been raised. The judgment "expensive vs. cheap relative to revenue" may sound the same at every stage, but what actually backs that judgment looks completely different depending on where the company sits.

The Discount Rate Shifts Too — Why Growth-Stage Companies Face a Higher Required Return

As discounted cash flow (DCF) explains, a company's value ultimately comes down to converting its future cash flows into today's money, and the discount rate used in that conversion moves with the life cycle stage as well. An early or high-growth company's business model is still unproven, and the risk that a competitor or a shift in technology could upend the whole business is comparatively larger. Beta, the measure of volatility relative to the market, also tends to run higher for these companies, which pushes up the required return in models like CAPM. A mature, stable company, by contrast, tends to see steadier demand and less volatile cash flow, earning it a lower discount rate even within the same industry. The life cycle transition, in other words, doesn't just reshape the cash flow going into the numerator — it reshapes the discount rate in the denominator at the same time. The same future cash flow of, say, $100 million is worth a very different amount today depending on whether it's a promise from a three-year-old company or a number a thirty-year-old company has delivered reliably, year after year.

Two Mistakes Investors Commonly Make

Missing this shift leads to backwards judgments in two directions. The first is applying mature-stage standards to a high-growth company: dismissing a stock as "way too expensive" at a 100x PER ignores the fact that its earnings are being suppressed by heavy reinvestment typical of the high-growth stage, not by a weak business. The second runs the other way — applying growth- or maturity-stage standards to a company in decline. Calling a stock "cheap" because its PER is only 5x can miss exactly the value trap dynamic covered elsewhere: that low multiple may be a perfectly justified discount for a business whose revenue and profit are structurally shrinking. Both mistakes share the same root cause — looking at a multiple in isolation, without first checking where the company sits on its life cycle and therefore what assumption that multiple was built on. The simplest guard against this is checking three numbers before looking at any multiple at all: revenue growth rate, operating margin, and reinvestment rate. That combination alone gives a rough sense of which stage a company is closest to, and only then does it become clear which valuation metric should be used to interpret the multiple in front of you.

A Numeric Illustration: The Same Company, Ten Years Apart

Consider a hypothetical software company, Company E, at two points in time. Six years after founding, in its high-growth stage, it's growing revenue 60% a year with a -10% operating margin — still unprofitable. Since there's no profit to put in the denominator, PER can't be calculated, so the market values it at 15x PSR instead. Ten years later, now in mature stability, revenue growth has slowed to 4% but operating margin has climbed to 25%, and the company has started returning a meaningful share of profit as dividends. The market now values it at 18x PER and 11x EV/EBITDA instead of PSR. Assuming the market is pricing both periods reasonably, the metric itself didn't change because the market got fickle — it changed because Company E's reinvestment rate, cash flow shape and estimation uncertainty actually changed. An investor who declares the six-year-old Company E "uninvestable" for lacking a PER, or insists a decade later that it should still be priced like a 15x-PSR growth stock, isn't really evaluating Company E at all — they're evaluating a different company, or an earlier version of this one.

Key Takeaways

• The corporate life cycle runs through five stages — early startup, high growth, mature growth, mature stable and decline — though not every company moves through them at the same pace.
• Each stage shift changes three things together: reinvestment rate, the shape of cash flow, and the uncertainty around future estimates — and these determine which valuation metric tends to apply.
• PSR for high-growth/unprofitable stages, PEG for profitable high growth, PER/EV-EBITDA/DCF for mature stability, and PBR/liquidation value for decline are common tendencies in practice, not fixed rules.
• The younger a company, the more its value rests on story; the more mature it becomes, the more it rests on numbers.
• Applying mature-stage standards to a growth company, or growth-stage standards to a declining one, is one of the most common valuation errors investors make.

FAQ

Does a high PSR at a growth company always mean it's overvalued?

Not necessarily. A high PSR is actually typical for an unprofitable, high-growth company. What matters more is whether the growth story behind it is credible, and whether it's unusually high even compared to other companies at a similar stage.

Should declining companies be avoided as investments altogether?

That's an individual stock-picking judgment outside the scope of this lesson. What is clear is that a declining company should be judged against decline-stage yardsticks — asset value, liquidation value, FCF yield — rather than growth- or maturity-stage standards.

Who decides which life cycle stage a company is in?

No official body assigns this. It's something investors gauge themselves by looking at revenue growth, operating margin, reinvestment rate (capex relative to revenue), and whether the company pays dividends or buys back stock — and different analysts can reasonably draw the boundaries differently for the same company.

⚠️ This lesson is for informational purposes only and is not investment advice. The figures used here are hypothetical illustrations for explaining the concept; responsibility for any actual investment decision rests with the investor.